These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 20070724

  • 1. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial.
    Karakus S, Kiran G, Ciralik H.
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):685-8. PubMed ID: 20070724
    [Abstract] [Full Text] [Related]

  • 2. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM, Bourgain C, Donoso P, Blockeel C, Papanikolaou EG, Popovic-Todorovic B, Devroey P.
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [Abstract] [Full Text] [Related]

  • 3. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S, Chattopadhyay R, Goswami S, Chaudhury K, Chakravarty B, Ganesh A.
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [Abstract] [Full Text] [Related]

  • 4. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V, Tomic J, Klaic DZ, Kasum M, Kuna K.
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [Abstract] [Full Text] [Related]

  • 5. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S.
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study on the effect of vaginal administration of micronized progesterone at dysfunctional uterine bleeding in premenopause].
    Kostova P, Zlatkov V.
    Akush Ginekol (Sofiia); 2009 Dec; 48(2):3-7. PubMed ID: 20198768
    [Abstract] [Full Text] [Related]

  • 7. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [Abstract] [Full Text] [Related]

  • 8. Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.
    Majhi P, Bagga R, Kalra J, Sharma M.
    J Obstet Gynaecol; 2009 Aug; 29(6):493-8. PubMed ID: 19697195
    [Abstract] [Full Text] [Related]

  • 9. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J, Abbott J, Hunter D, Phillips G, Garry R.
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [Abstract] [Full Text] [Related]

  • 10. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.
    Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B.
    Fertil Steril; 2011 May; 95(6):1961-5. PubMed ID: 21333984
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N, Zamaniyan M, Salehpour S, Zadehmodarres S, Hoseini S, Cheraghi L, Seif S, Baheiraei N.
    Gynecol Endocrinol; 2016 May; 32(3):213-7. PubMed ID: 26486011
    [Abstract] [Full Text] [Related]

  • 12. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
    Schindler AE.
    Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
    [Abstract] [Full Text] [Related]

  • 13. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor.
    How HY, Leaseburge L, Khoury JC, Siddiqi TA, Spinnato JA, Sibai BM.
    Am J Obstet Gynecol; 2001 Oct; 185(4):911-5. PubMed ID: 11641677
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of oral micronized progesterone when applied via vaginal route.
    Choavaratana R, Manoch D.
    J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
    [Abstract] [Full Text] [Related]

  • 15. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.
    Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofsson JI, Driessen S, Tournaye H.
    PLoS One; 2020 May; 15(11):e0241044. PubMed ID: 33147288
    [Abstract] [Full Text] [Related]

  • 16. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients.
    Stadtmauer L, Harrison DD, Boyd J, Bocca S, Oehninger S.
    Fertil Steril; 2009 Nov; 92(5):1600-5. PubMed ID: 18990373
    [Abstract] [Full Text] [Related]

  • 17. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M, Finas A, Katalinic A, Strik D, Kowalcek I, Schwartz P, Felberbaum R, Küpker W, Schöpper B, Al-Hasani S, Diedrich K.
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [Abstract] [Full Text] [Related]

  • 18. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A, Hochner-Celnikier D, Lindenberg T, Zacut D, Shimonovitz S, Gelber H, Spitz IM.
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [Abstract] [Full Text] [Related]

  • 19. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
    Patki A, Pawar VC.
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():68-72. PubMed ID: 17943542
    [Abstract] [Full Text] [Related]

  • 20. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial.
    Dickersin K, Munro MG, Clark M, Langenberg P, Scherer R, Frick K, Zhu Q, Hallock L, Nichols J, Yalcinkaya TM, Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Research Group.
    Obstet Gynecol; 2007 Dec; 110(6):1279-89. PubMed ID: 18055721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.